An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus
Ho-Chuen Leung(University of Hong Kong), Bo‐Jian Zheng(University of Hong Kong), Chung Yan Cheung(Broad Institute), Fai Ng(University of Hong Kong), Hanjun Zhao(University of Hong Kong), Vincent Kwok‐Man Poon(Queen Mary Hospital), Jian‐Dong Huang(Sun Yat-sen University), Chris Chung‐Sing Chan(University of Hong Kong)
Cited by 25
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility
|Clinical Infectious Diseases|2020|1.2k
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
|Clinical Infectious Diseases|2020|818
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|700